Oral suspension - 160 mg / 5 ml

Syrup - 120 mg / 5 ml

Suppositories - 125 mg

Suppositories - 250 mg

Suppositories - 100 mg

Solution for infusion - 1000 mg / 100 ml

Film coated tablets - 251 mg + 61.2 mg + 2.54 mg

Tablets - 350 mg + 50 mg

Tablets - 500 mg + 30 mg

 Co-DOLOR contains a combination of the active substances paracetamol and codeine phosphate hemihydrate, a combination of the group of drugs called analgesics, which act as painkillers. Paracetamol acts also as an antipyretic (lowers high temperature), while codeine belongs to a group of drugs called opioid analgesics which relieve pain.

Co-DOLOR is used for the short - term treatment of acute moderate or severe pain that is not relieved by other analgesics such as ibuprofen or paracetamol used alone.

This codeine-containing medicine is indicated in adults and children aged 12 years and over.

Tablets - 500 mg + 30 mg

Co-DOLOR contains a combination of the active substances paracetamol and codeine phosphate hemihydrate, a combination of the group of drugs called analgesics, which act as painkillers. Paracetamol acts also as an antipyretic (lowers high temperature), while codeine belongs to a group of drugs called opioid analgesics which relieve pain.

Co-DOLOR is used for the short - term treatment of acute moderate or severe pain that is not relieved by other analgesics such as ibuprofen or paracetamol used alone.

This codeine-containing medicine is indicated in adults and children aged 12 years and over.

Film coated tablets - (251 mg + 61.2 mg + 2.54 mg)

Solution for injection - (5%) 100 mg/2 ml

Tablets - 15 mg

Luminal contains as active substance phenobarbital, which is part of the group of barbiturates. It may affect the brain activity at different levels, from excitation to mild sedation to hypnosis and coma. High therapeutic doses of barbiturates may produce anesthesia. Overdoses may cause death. Phenobarbital depresses the sensory cortex, decreases motor activity, alters cerebellar function and causes drowsiness, sedation and hypnosis. Barbiturates have poor analgesic activity in subanesthetic doses and may increase the response to painful stimuli. All barbiturates exhibit anticonvulsant action at anesthetic doses. Barbiturates are respiratory depressants. The degree of respiratory depression is dependent upon the dose. Barbiturates are absorbed in varying degrees following oral or parenteral administration. The salts are absorbed faster than the acids. The rate of absorption is increased if sodium salts are given as a dilute solution or taken on an empty stomach. The onset of action ranges from 20 to 60 minutes after oral administration. After intramuscular injection, the onset of action is more rapid, while after intravenous administration the action may start after 5 minutes. Maximal depression of central nervous system may not occur until 15 minutes after intravenous injection.

Luminal is used:

• as long-term treatment of generalised tonic-clonic and focal-cortical seizures;
• as part of the emergency treatment of acute convulsions, including status epilepticus;
• as short-term treatment of insomnia;
• as preanesthetic sedation;
• in the treatment of febrile seizures in children.

Tablets - 60 mg

Solution for injection - (10%) 200 mg/2 ml

Eye drops, solution - 20 mg/1 ml - 10 ml

Tablets - 250 mg

Piperazine is an antihelmintic that acts against roundworms (Ascaris lumbricoides) and pinworms (Enterobius vermicularis). In roundworms, piperazine causes neuromuscular block leading to muscle paralysis of these parasites, which then are easily dislodged from their position by the movement of the gut and expelled in the faeces.

Piperazine 250 mg tablets are indicated in the treatment of ascaridiasis and enterobiasis.

Tablets 20 mg

Solution for injection - 750 mg/10 ml

Potassium participates in a number of essential physiological processes, such as maintenance of intracellular tonicity and a proper report with sodium in the cell membrane, cell metabolism, transmission of nerve impulses, contraction of the heart muscle, skeletal and smooth muscles; acid-base balance and maintaining normal kidney function. Normal levels of potassium in serum range from 3.5 to 5 milliequivalent / L.

Klorur kaliumi is indicated for the correction of severe hypokalemia and when sufficient quantities of potassium cannot be taken by mouth.

Solution - 100 mg/ml